Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
08/2010
08/11/2010CN101797389A Method for preparing colon cancer chemotherapy medicament
08/11/2010CN101797383A Hydro-acupuncture preparation of monoclonal antibody
08/11/2010CN101797382A Anti-human progastrin polypeptide immune composition
08/11/2010CN101797368A Medicinal liquor for treating cancer by great formulation
08/11/2010CN101797367A Traditional Chinese medicinal capsule for treating hysteromyoma and preparation method thereof
08/11/2010CN101797366A Drug composition for treating tumor
08/11/2010CN101797340A Composite drug for curing esophageal carcinoma and preparation method thereof
08/11/2010CN101797333A Medicinal composition for treating intracranial tumours
08/11/2010CN101797328A Production process of Zhenqi capsule and test method thereof
08/11/2010CN101797324A Medicinal composition for treating leukemia
08/11/2010CN101797319A Medicament for treating cancer diseases and preparation method thereof
08/11/2010CN101797282A Novel compound propolis preparation and preparation method thereof
08/11/2010CN101797249A Medicinal composition containing pyridyl cyanoguanidine as well as preparation and application thereof
08/11/2010CN101797247A Application of isoflavone compound in preparation of anti-tumor drug or food
08/11/2010CN101797242A Application of cysteamine in preparing medicine for treating cancer
08/11/2010CN101797232A Method for preparing small-granularity recombination human vascular endothelium inhibin slowly-released particle for injection
08/11/2010CN101797229A Immune liposome based on Isthmin gene as well as preparation method and application thereof
08/11/2010CN101797220A Oxaliplatin chitosan-stearic acid grafting micelle and application
08/11/2010CN101797219A Solid sustained- release implant for curing esophageal carcinoma and preparation method thereof
08/11/2010CN101618188B Traditional Chinese medicine plaster for treating malignant tumors and preparation method and application thereof
08/11/2010CN101485447B Ferulaic acid cyclodextrin inclusion compound preparation method
08/11/2010CN101485446B Preparation method of garlic oil cyclodextrin or cyclodextrin derivate inclusion compound
08/11/2010CN101455660B Use of glaucocalyxin X in preparing anti-cancer medicine
08/11/2010CN101411690B 2-methoxyestradiol lipidosome freeze-dried injection and preparation method thereof
08/11/2010CN101397346B Method for preparing asparagus pure polysaccharide having immunoregulation role
08/11/2010CN101353333B 10- deacetylate-9(R)-hydrogenization-1-deoxypaclitaxel analogue and preparation thereof
08/11/2010CN101317869B Method for extracting flavone from capillary wormwood
08/11/2010CN101270143B Triterpene saponin antineoplastic compound, preparing method and uses
08/11/2010CN101259100B Etoposide preparations and preparation thereof
08/11/2010CN101250119B Dinaphthol derivatives as well as preparation method and uses thereof
08/11/2010CN101229184B DNA degradation fragment compound and applications thereof
08/11/2010CN101194917B Grifola frondosa oral liquid rich in gastrodine, organic selenium and method for preparing the same
08/11/2010CN101190925B Copper complex, preparation method and application thereof
08/11/2010CN101066081B Agrimonia herb green tea
08/11/2010CN101011438B Use of asafetida in the process for preparing anti-cancer medicament
08/11/2010CN101011426B Medicated wine for treating cancer and preparing process thereof
08/11/2010CN101011145B Edible Collybia albuminosa(Berk.) Petch stuffing
08/10/2010US7772397 derivatives of Hemiasterlin or Geodiamolide G; pyrido(3,4-B)indole amides; extraction from marine sponges; anti-mitotic and carcinogenic agent; cause mitotic arrest and produce abnormal mitotic spindles
08/10/2010US7772386 immunization against Mycobacterium tuberculosis; purified nucleic acid molecule coding for oxidoreductase from M. tuberculosis; production of a vaccine against a virulent strain of M. tuberculosis
08/10/2010US7772373 Major histocompatibility complex specific immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative, inflammatory, autoimmune, liver and kidney disorders
08/10/2010US7772372 Neoplasm specific antibodies and uses thereof
08/10/2010US7772265 2-oxadiazolechromone derivatives
08/10/2010US7772249 Imidazo[1,2-b]pyridazine compound
08/10/2010US7772247 vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) receptor antagonists such as 1-(4-(2-(N-methoxy-N-methylcarbamoyl)thieno[3,2-b]pyridin-7yloxy)-3-fluorophenyl)-3-(2-phenylacetyl)thiourea, used as antiproliferative agents
08/10/2010US7772241 fused pyrido[3'.2':4.5]pyrrolo[1.2-c]pyrimidine's used for treating cancer in mammals
08/10/2010US7772233 Arylamino N-heteroaryl compounds as MEK inhibitors
08/10/2010US7772231 such as cis-4-(4-(4-amino-3-(2-phenyl-1H-benzimidazol-6-yl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)cyclohexyl)-1-methylpiperazin-2-one, used as anticarcinogenic agents
08/10/2010US7772226 such as 3-(2-Butynyl)-2-(piperazin-1-yl)-3,5-dihydroimidazo[4,5-d]pyridazin-4-one trifluoroacetate, used as dipeptidyl peptidase-IV (DPPIV) inhibitors for the treatment of obesity and diabetes
08/10/2010US7772209 Antifolate combination therapies
08/10/2010US7771998 Pharmaceutical composition for inducing an immune response in a human or animal
08/10/2010US7771979 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
08/10/2010US7771963 Methods for determining efficacy of chemotherapeutic agents
08/10/2010US7771962 screening for a therapeutic oligopeptide for treatment of tumor disorders; contacting the tumor with a therapeutically effective amount of a CD10 cleavable prodrug, wherein tumor is comprised of one or more target cells which express CD10 for at least a portion of the target cell life cycle
08/10/2010US7771931 Using presence of allelic mutation in protein kinase c gene as diagnostic indication of heart disease
08/10/2010US7771930 Identifying mutation in nucleotide sequences coding immunoglobulin domain carrying polypeptide for use in diagnosis and prognosis of cell proliferative disorders
08/10/2010US7771739 Implantable medical devices comprising semi-crystalline poly(ester-amide)
08/10/2010US7771723 Remedies for myeloma to be used together with nitrogen mustard antitumor agents
08/10/2010US7771721 Methods for using chimeric vascular endothelial growth factor receptor proteins
08/10/2010US7771714 Effective as an anti-differentiator while the chicken differentiable cell is being cultured; enables stable supply of the LIF protein derived from chickens
08/10/2010CA2606719C Amorphous salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide and process for producing the same
08/10/2010CA2487252C Esters in position 20 of camptothecins
08/10/2010CA2473680C Compositions and methods for the modulation of sphingolipid metabolism and/or signaling
08/10/2010CA2467013C Substituted benzopyrans as selective estrogen receptor-beta agonists
08/10/2010CA2463227C Steroidal compounds for inhibiting steroid sulphotase
08/10/2010CA2447021C Pyridyl cyanoguanidine compounds
08/10/2010CA2440714C Pyrazolopyrimidines as therapeutic agents
08/10/2010CA2395980C 10, 11-difluoromethylenedioxycamptothecin compounds with topoisomerase i inhibition
08/10/2010CA2391507C Immunomodulatory compositions containing an immunostimulatory sequence linked to antigen and methods of use thereof
08/10/2010CA2389647C Isoxazole derivatives as phosphodiesterase vii inhibitors
08/10/2010CA2383493C Treating prostate cancer with anti-erbb2 antibodies
08/10/2010CA2366800C Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
08/10/2010CA2361617C Uses of thank, a tnf homologue that activates apoptosis
08/10/2010CA2361238C Use of a melanoma inhibiting activity factor (mia) for cartilage and bone repair
08/10/2010CA2319309C Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccination
08/10/2010CA2267095C Nucleotide and protein sequence of mammastatin and methods of use
08/10/2010CA2243235C Immunotherapy using cytotoxic t lymphocytes (ctl)
08/10/2010CA2237099C Sulfonylaminocarboxylic acids
08/10/2010CA2215827C O-malonyltyrosyl compounds, o-malonyltyrosyl compound-containing peptides, and uses thereof
08/10/2010CA2180032C Gene expression control
08/10/2010CA2165969C Vertebrate apoptosis gene: compositions and methods
08/05/2010WO2010088564A2 Compositions and methods for the treatment of cancer
08/05/2010WO2010088527A2 Peptides and nanoparticles for therapeutic and diagnostic applications
08/05/2010WO2010088368A2 Imidazopyrazines as protein kinase inhibitors
08/05/2010WO2010088304A1 Vitamin d3 and analogs thereof for alleviating side effects associated with chemotherapy
08/05/2010WO2010088203A1 Therapeutic treatment of cancer and dysplasia of the cervix or vagina using estrogen antagonists
08/05/2010WO2010087517A1 Prophylactic or therapeutic agent for diseases associated with abnormal bone metabolism
08/05/2010WO2010087497A1 Pharmaceutical composition, and pharmaceutical preparation for treating tumors
08/05/2010WO2010087425A1 Prostate cancer progression inhibitor and progression inhibition method
08/05/2010WO2010087335A1 T CELL ANTIGEN RECEPTOR GENE, VECTOR FOR EXPRESSION OF RECEPTOR α-CHAIN AND β-CHAIN, AND CYTOTOXIC T CELL
08/05/2010WO2010087313A1 Neurite elongation stimulator
08/05/2010WO2010087107A1 Melanoma metastasis inhibitor
08/05/2010WO2010086964A1 Combination therapy for treating cancer
08/05/2010WO2010086709A1 Proteinase-engineered cancer vaccine induces immune responses to prevent cancer and to systemically kill cancer cells
08/05/2010WO2010086646A1 Scriptaid isosteres and their use in therapy
08/05/2010WO2010086613A1 Compounds useful as inhibitors as ampk
08/05/2010WO2010086454A1 N-(phenyl or pyridyl)prenylamine derivatives for the treatment of obesity, diabetes, cardiovascular diseases and other adiponectin-related diseases
08/05/2010WO2010086445A1 Tslp promotes immune evasion and persistence of viruses
08/05/2010WO2010086185A1 Nampt and vitamin b3 for treating or preventing diseases
08/05/2010WO2010085968A1 Toluidine sulfonamides and their use as hif-inhibitors
08/05/2010WO2010085876A1 Thylakoids and their functional derivatives, and their uses
1 ... 655 656 657 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 ... 2211